No Data
No Data
Actinogen Medical Doses First Participant in Alzheimer's Disease Trial in US; Shares Rise Nearly 7%
This Biotech Stock Raised $11M in a Risk-off Environment. Its Alzheimer's Drug Could Change the Game
Actinogen Receives $9M R&D Tax Rebate to Fund Alzheimer's Trial
Actinogen Medical Ltd: Actinogen receives $9.0 million R&D tax incentive rebate
Actinogen Medical Ltd: Annual Report to Shareholders
Actinogen Medical Completes AU$8.1 Million Placement, Launches AU$3 Million Share Purchase Plan; Shares Fall 9%
No Data
151479178 : What are you talking about